Is Being Cold a Side Effect of Mounjaro? Exploring Cold Sensitivity in Patients

Last reviewed: July 17, 2026

Last updated: July 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, a dual GLP-1 and GIP receptor agonist, has shown remarkable results for weight management in clinical trials. However, some patients experience heightened cold sensitivity during treatment—a symptom that warrants explanation and practical strategies for relief.

Why Tirzepatide Can Make You Feel Colder

Tirzepatide works by activating receptors in the brain and gut that regulate appetite and blood sugar. As your body loses weight and your metabolism adjusts, thermogenesis—the process of heat generation—can temporarily decline. This metabolic shift may cause you to feel colder than before treatment, especially in cooler environments or during early dose escalation phases.

The medication also affects satiety signaling, which can influence how your body prioritizes energy distribution. During rapid weight loss, your body may redirect resources away from peripheral heat production to preserve core function. This adaptation typically lessens as your body reaches a new metabolic equilibrium after several months of treatment.

Temperature Sensitivity During Weight Loss: The Mechanism

Clinical data shows that patients losing more than 10% of baseline body weight often experience transient cold sensitivity. This occurs because brown adipose tissue—which generates heat through a process called thermogenesis—becomes less active as overall fat stores decrease. Additionally, reduced subcutaneous fat provides less natural insulation, intensifying the sensation of cold exposure.

Tirzepatide's appetite-suppressing effects may also lead to reduced caloric intake, which can temporarily lower your body's basal metabolic rate. When combined with significant weight loss, this creates a metabolic environment where your core body temperature regulation operates at a lower set point. Most patients report this effect diminishes within 3–6 months as their body adapts to its new weight.

Practical Strategies to Manage Cold Sensitivity on Tirzepatide

LayerLayering clothing is the first-line approach: wear moisture-wicking base layers, insulating middle layers, and a windproof outer layer. Keep a lightweight jacket or sweater at your desk and in your car. Increase your intake of warming beverages like herbal tea, warm water with lemon, or bone broth—these support hydration without excessive calories and provide psychological warmth.

Boost thermogenesis naturally through light resistance exercise, which builds muscle tissue and increases metabolic heat production. Aim for 2–3 sessions of strength training weekly, as this can counteract the metabolic slowdown associated with rapid weight loss. Additionally, ensure adequate protein intake (25–30 grams per meal) to maintain muscle mass during treatment, which helps preserve your body's heat-generating capacity.

Stay mindful of environmental factors: avoid prolonged exposure to air-conditioned spaces, keep your home thermostat at a comfortable setting, and consider using a heating pad or weighted blanket during rest periods. If cold sensitivity persists beyond six months or feels severe, contact your PlexusDx provider to discuss whether dose adjustments or supplementary strategies might help.

When Cold Sensitivity Signals a Need for Medical Review

While mild cold sensitivity is common during tirzepatide treatment, extreme or prolonged cold intolerance—particularly if accompanied by fatigue, muscle weakness, or unexplained weight plateaus—warrants evaluation by your healthcare provider. These symptoms may indicate inadequate caloric intake, electrolyte imbalance, or thyroid dysfunction that requires clinical assessment.

PlexusDx recommends tracking your cold sensitivity alongside other side effects in your treatment journal. Note when it began, whether it's improving or worsening, and how significantly it impacts your daily activities. This information helps your provider distinguish between expected metabolic adaptation and potential complications requiring intervention. If you're on Compounded Tirzepatide Injection from PlexusDx (at $289/mo month-to-month, or from $249/mo on the 6-month plan), your dedicated support team can review these patterns during check-ins and coordinate with your prescribing clinician.

Personalized Treatment: Genetic Insights Into Temperature Regulation

The PlexusDx Precision Peptide Genetic Test ($298) analyzes FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The test maps 14 distinct metabolic pathways and 49 peptides involved in weight regulation and heat production. Patients with certain genetic predispositions may experience more pronounced cold sensitivity during the first 8–12 weeks of treatment. With this knowledge, PlexusDx and your provider can personalize your dose escalation schedule and supportive strategies to minimize discomfort while maximizing the therapeutic benefits of tirzepatide.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is feeling cold a normal side effect of tirzepatide?

Yes, mild to moderate cold sensitivity is reported by some patients, particularly during the first few months of treatment and rapid weight loss phases. It typically resolves as your body adapts. However, if it's severe or persistent beyond six months, discuss it with your provider.

How long does cold sensitivity usually last on tirzepatide?

Most patients experience peak cold sensitivity during weeks 4–12 of treatment. By month four to six, as your metabolism stabilizes at your new weight, cold sensitivity typically improves significantly. Individual timelines vary based on the speed of weight loss and your personal metabolic adaptations.

Can I prevent cold sensitivity before starting tirzepatide?

You cannot completely prevent it, but you can minimize its impact: maintain adequate protein intake before starting treatment, incorporate strength training to preserve muscle mass, and prepare warm clothing and layering strategies in advance. These approaches support metabolic stability during your weight loss journey.

Is compounded tirzepatide from PlexusDx different from brand-name Mounjaro regarding side effects?

PlexusDx Compounded Tirzepatide Injection is formulated by licensed 503A compounding pharmacies and contains the same active ingredient as brand-name Mounjaro. Side effect profiles, including cold sensitivity, are comparable. PlexusDx is $289/mo month-to-month with no insurance required, making it more accessible.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The Precision Peptide Genetic Test analyzes variants in the FTO and MC4R genes that regulate both appetite and thermogenesis. Certain genetic profiles correlate with greater sensitivity to metabolic shifts during weight loss. This $298 test helps personalize your treatment plan and anticipate side effects.

What should I eat to combat cold sensitivity on tirzepatide?

Prioritize warming, protein-rich foods: bone broth, warm fish or chicken, lentil soup, and herbal teas. Aim for 25–30 grams of protein per meal to preserve muscle mass and thermogenic capacity. Avoid excessive cold or ice-cold beverages, which can intensify the sensation of cold sensitivity.

Related Reading

• Mounjaro Side Effects Plexusdx
• Mounjaro Side Effects
• Hers Mounjaro
• Hims Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.